𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure

✍ Scribed by Tomoko Asakawa; Yusuke Moritoh; Osamu Kataoka; Nobuhiro Suzuki; Koji Takeuchi; Hiroyuki Odaka


Book ID
116719613
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
617 KB
Volume
85
Category
Article
ISSN
0024-3205

No coin nor oath required. For personal study only.